Global Health (NSE:MEDANTA) Tariff Resilience Score: 0/10 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDANTA Global Health Ltd NSE:MEDANTA
95 GF Score
Price ₹1,480.40
GF Value ₹1,572.54
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Global Health Tariff Resilience Score?

Global Health has the Tariff Resilience Score of 0, which implies that the company might have .

Global Health has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Global Health might have .

Global Health  (NSE:MEDANTA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Global Health Tariff Resilience Score Related Terms

NSE:MEDANTA
95GF Score
Global Health Ltd NSE:MEDANTA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Global Health (NSE:MEDANTA) Overvalued in 2026?

Based on GuruFocus' analysis, Global Health stock appears to be undervalued. The current stock price of ₹1,480.40 is trading 5.9% below its estimated GF Value™ of ₹1,572.54. GuruFocus considers Global Health to be Fairly Valued.

Key valuation signals for NSE:MEDANTA:

  • Tariff Resilience Score: 0
  • GF Value™: ₹1,572.54 vs. price of ₹1,480.40 (5.9% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the NSE:MEDANTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Global Health Business Description

Other Exchanges 543654:India
Address Medanta - The Medicity, Sector-38, Gurugram, HR, IND, 122001
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
95GF Score

Get the complete analysis for NSE:MEDANTA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,480.40
Price
₹1,572.54
GF Value